BMO Capital: 'Allstate (ALL) Biggest Beneficiary of Insurance Reforms'
Tweet Send to a Friend
BMO Capital analyst Michael Zaremski reiterated an Outperform rating and $249.00 price target on Allstate (NYSE: ALL).The analyst commented: "Allstate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


